Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTP889 in LVAD Patients
NCT00909298Phase 2Terminated
- Sponsor
- vTv Therapeutics
- Start
- Jun 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TTP889 in thrombosis, sponsored by vTv Therapeutics. Started Jun 2009; status: terminated.
02
Drugs
TTP889
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT00909298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909298.